Nebenwirkungen · Inhixa
Inhixa 100,000 IU (1000 mg)/10 mL solution for injection in multidose container · Abschnitt 4.8 · PDF-Seite 269
HOS-137258 · Präparat HOS-097950
Thrombocytopenia and thrombocytosis (see section 4.4 monitoring of platelet counts) System Prophylaxis Prophylaxis Treatment in Extended Treatment in Treatment in organ in surgical in medical patients with treatment of patients with patients with class patients patients DVT with or DVT and PE unstable acute STEMI without PE in patients angina and with active non-Q-wave cancer MI Blood Very Uncommon: Very common: Unknown: Uncommon: Common: and common: Thrombo- Thrombo- Thrombocyto Thrombo- Thrombocytos lympha Thrombo- cytopenia cytosisβ penia cytopenia isβ Thrombo- β tic cytosis cytopenia system Common: Very rare: disorde Common: Thrombo- Immuno- rs Thrombo- cytopenia allergic cytopenia thrombo- cytopenia β : Platelet increased >400 G/L
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-16T09:35:00Z · SHA-256 bbb8302fcca3a170cc14307df6fa307c1fd979d2c3ae4a14f42ba825950d23d7 · Passage 48c0040d5969c501470b6dda1e19e563259555cfc12880693a8b9bffdc8174e9 · Zeichen 7199–8902 im Abschnitt